Rockefeller Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1M Buy
35,317
+12,214
+53% +$3.24M 0.03% 532
2026
Q1
$2.53M Buy
23,103
+2,575
+13% +$367K ﹤0.01% 1205
2025
Q4
$3.42M Sell
20,528
-7
-0% -$1.17K 0.01% 1016
2025
Q3
$4.02M Buy
20,535
+8,067
+65% +$1.33M 0.01% 900
2025
Q2
$1.13M Buy
12,468
+539
+5% +$42.6K ﹤0.01% 1281
2025
Q1
$712K Buy
+11,929
New +$1.1M ﹤0.01% 1379

Other funds holding ALAB

Rockefeller Capital Management's ALAB Position: Q2 2026 in Review

Rockefeller Capital Management increased its Astera Labs (ALAB) stake by 53% in Q2 2026, buying an estimated $3.24M and bringing the position to 35,317 shares worth $17.1M. The position accounts for 0.03% of the portfolio, ranked #532.

Rockefeller Capital Management first reported a position in ALAB in Q1 2025 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Rockefeller Capital Management held 35,317 shares of Astera Labs worth $17.1M as of Q2 2026.
  • Rockefeller Capital Management bought 12,214 Astera Labs shares in Q2 2026, an estimated $3.24M.
  • Astera Labs made up 0.03% of Rockefeller Capital Management's portfolio in Q2 2026, its #532 holding.
  • Rockefeller Capital Management first reported a position in Astera Labs in Q1 2025 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.